BAC
Bank of America Corporation
BAC has the edge over NODK overall, supported by stronger valuation and stronger fundamentals.
NODK
NI Holdings, Inc.
NODK has slightly lower modeled downside risk, despite its lower overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NODK Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| N/A | |
| N/A |
NODK's profitability is currently strong, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like NODK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over NODK in the historical PE scenario, which offers more potential upside but is not a forecast.
NODK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $7.54 | -50% |
| Fair | 17x | $12.02 | -20% |
| Current | 21x | $14.97 | — |
| Expensive | 96x | $69.38 | +363% |
Historical ranges are pointers, not guarantees.
NODK's PE is in its fair range at 21x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
NODK Forward outlook
There aren't enough analyst estimates for NODK to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over NODK on earnings, with more consistent year-over-year improvement.
NODK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.72 | +414% |
| Q2 2026 | $0.37 | +311% |
| Q1 2026 | -$0.21 | +$0.07 |
| Q4 2025 | -$0.50 | -$0.21 |
| Q3 2025 | $0.14 | +$0.60 |
| Q2 2025 | $0.09 | +$0.41 |
| Q1 2025 | -$0.28 | -217% |
| Q4 2024 | -$0.29 | -$0.03 |
NODK's earnings per share have fallen from their peak: $0.72 over the past year, against $2.47 in early 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over NODK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over NODK on profitability, with a higher operating margin.
NODK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $68.6M | -10% |
| Q2 2026 | $70.2M | -7.7% |
| Q1 2026 | $59.6M | -17% |
| Q4 2025 | $61M | -17% |
| Q3 2025 | $76.6M | -14% |
| Q2 2025 | $76.1M | -13% |
| Q1 2025 | $71.4M | -22% |
| Q4 2024 | $73.9M | -22% |
NODK's revenue has slid since its 2023 peak: $69M last quarter, down 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +13 points |
| Q2 2026 | 0.3% | +21 points |
| Q1 2026 | 26% | +16 points |
| Q4 2025 | -4.8% | -24 points |
| Q3 2025 | -2.4% | +1.4 points |
| Q2 2025 | -20% | -9.8 points |
| Q1 2025 | 11% | +1.9 points |
| Q4 2024 | 19% | +6.5 points |
NODK's operating margin was 10% last quarter, up 13 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over NODK on cash generation, producing positive trailing cash flow while its opponent burns cash.
NODK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15.3M | +$29.6M |
| Q2 2026 | $893K | -86% |
| Q1 2026 | -$1.9M | -119% |
| Q4 2025 | $13.2M | -38% |
| Q3 2025 | -$44.8M | -$26.7M |
| Q2 2025 | $6.2M | -65% |
| Q1 2025 | $9.9M | -39% |
| Q4 2024 | $21.5M | -26% |
NODK's free cash flow was −$3M over the past year, against −$7M the year before. Free cash flow isn't a meaningful measure for financial services companies like NODK.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over NODK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NODK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -58.4K shares |
| 1 year | -0.9% | -185K shares |
| 3 years | -1.8% | -377K shares |
| 5 years | -2.8% | -595K shares |
| Available history | -6.5% | -1.4M shares |
NODK has 21M diluted shares, down 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | $2.6M |
| Q1 2023 | $621,000 |
| Q4 2022 | $1.3M |
| Q3 2022 | $939,000 |
| Q2 2022 | $934,000 |
| Q1 2022 | $997,000 |
| Q4 2021 | $1.1M |
| Q3 2021 | $944,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NODK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2026 | -4.1x | Net Cash |
| Q3 2025 | -4.4x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
| Q3 2024 | -4.5x | Net Cash |
| Q2 2024 | -4.1x | Net Cash |
| Q1 2024 | -6.2x | Net Cash |
| Q4 2021 | -5.3x | Net Cash |
NODK has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NODK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 29.3 | Neutral |
NODK's weekly RSI is 52 (neutral) and its Stochastic is 29 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over NODK on valuation relative to its sector.
NODK PE vs Financial Services Sector
| Metric | NODK | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 13x | 60% above |
| PE % | 54 | 63 | 9 pts below |
NODK is trading at 21x earnings, a 60% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
NODK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 0.2% above |
| 20 week MA | $15.3 | 1.8% below |
| 50 week MA | $14.3 | 4.8% above |
| 100 week MA | $13.9 | 7.4% above |
| 200 week MA | $14.0 | 6.6% above |
NODK has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
NODK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $16.7 | -3.5% |
| 2021 | $16.7 | $19.0 | +14% |
| 2022 | $19.0 | $13.4 | -30% |
| 2023 | $13.4 | $13.0 | -2.8% |
| 2024 | $13.0 | $15.7 | +21% |
| 2025 | $15.7 | $13.5 | -14% |
| 2026 YTD | $13.5 | $15.0 | +11% |
NODK has the edge over BAC on returns for 2026, with the stronger performance.